Displaying 31 - 35 of 50
Mon 25 November 2013
A parliamentary Inquiry has concluded that NHS treatment for pancreatic cancer is not patient-centered, well co-ordinated or efficient. The All-Party Parliamentary Group (APPG) on Pancreatic Cancer warns that much greater focus and resource is needed in order tackle this disease, which is set to overtake breast cancer as the 4th biggest cancer killer in the UK by 2030.Read More about 'APPG inquiry report sets out national plan for pancreatic cancer'
Fri 01 November 2013
Pancreatic Cancer UK welcomes the Royal College of Physicians' new toolkit 'Acute oncology on the acute medical unit'.Read More about 'New toolkit aims to improve care of emergency-admitted cancer patients'
Thu 31 October 2013
Pancreatic Cancer UK is calling on the Government to urgently address late diagnosis of pancreatic cancer in order to significantly improve survival of the disease, ahead of November's Pancreatic Cancer Awareness Month.Read More about 'Call for Government to urgently address late diagnosis'
Wed 04 September 2013
Pancreatic Cancer UK has released research that shows if pancreatic cancer diagnosses as a result of emergency presentation were reduced to 25 per cent, as many as 150 additional patients would survive for a year or longer.Read More about 'Reducing pancreatic cancer diagnoses via emergency admission could significantly improve survival'
Mon 02 September 2013
The Cancer Drugs Fund Panel recently (30th July 2013) took the decision not to approve Abraxane (Paclitaxel Albumin) for the National Cancer Drugs Fund List for the treatment of advanced pancreatic cancer.Read More about 'Abraxane not approved by Cancer Drugs Fund Panel'